McKesson Corp Stock Forecast for 2023 - 2025 - 2030
Updated on 03/28/2024
McKesson Corp Stock Forecast and Price Target
If the average 2024 price target of $560.00 recently set by three prominent experts for McKesson Corp is met, there would be a potential upside of approximately 6.33% from the last closing price in March, 2024. The high estimate is $620.00, and the low is $410.00. Although you may not be interested in MCK stock, you should still be aware of its competitors.
6.33% Upside
McKesson Corp Fair Value Forecast for 2023 - 2025 - 2030
McKesson Corp's Price has increased by 73.51% In the last three years, going from $161.76 to $280.67. In the following year, the 9 analysts surveyed believe that McKesson Corp's Fair Value will decrease by 2.08%, reaching $274.83. For the next seven years, the forecast is for Fair Value to grow by 44.52%.
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
ABC Stock Forecast | Abcam PLC | Outperform |
7
|
£237.68 | Buy/Sell | £246.00 | 9.81% |
CAH Stock Forecast | Cardinal Health Inc | Hold |
13
|
$115.48 | Buy/Sell | $108.07 | -0.42% |
PBH Stock Forecast | Prestige Consumer Healthcare | Outperform |
16
|
$74.58 | Buy/Sell | $71.50 | -0.11% |
PINC Stock Forecast | Premier | Hold |
16
|
$21.43 | Buy/Sell | $24.14 | 11.99% |
HLF Stock Forecast | Herbalife | Outperform |
16
|
$9.61 | Buy/Sell | $17.90 | 24.87% |
McKesson Corp Revenue Forecast for 2023 - 2025 - 2030
McKesson Corp's Revenue has increased by 19.76% In the last three years, going from $231.05B to $276.71B. In the following year, the 8 analysts surveyed believe that McKesson Corp's Revenue will decrease by 5.85%, reaching $260.53B. For the next seven years, the forecast is for Revenue to grow by 35.69%.
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
RXMD Stock Forecast | Progressive Care | - |
0
|
$2.60 | Buy/Sell | $20.00 | -100.00% |
COSM Stock Forecast | Cosmos Health | - |
0
|
$0.83 | Buy/Sell | $0.00 | -100.00% |
PDRX Stock Forecast | PD-Rx Pharmaceuticals | - |
0
|
$4.91 | Buy/Sell | $0.00 | -100.00% |
McKesson Corp Dividend per Share Forecast for 2023 - 2025 - 2030
In the last three years, McKesson Corp's Dividend per Share has grown, increasing from $1.62 to $2.09 – a growth of 29.01%. The next year, 5 experts forecast that McKesson Corp's Dividend per Share will decrease by 5.74%, reaching $1.97. Over the next seven years, experts anticipate that McKesson Corp's Dividend per Share will grow at a rate of 29.19%.
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
SMEV Stock Forecast | Simulated Environment Concepts | - |
0
|
$0.01 | Buy/Sell | $0.00 | -100.00% |
SKWG Stock Forecast | Skywealth Group | - |
0
|
$1.28 | Buy/Sell | $0.00 | -100.00% |
AXRX Stock Forecast | Amexdrug | - |
0
|
$0.00 | Buy/Sell | $0.00 | 0.00% |
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
PHRX Stock Forecast | Pharmagen | - |
0
|
$0.00 | Buy/Sell | $0.00 | 0.00% |
SPPH Stock Forecast | Spencer Pharmaceutical | - |
0
|
$0.00 | Buy/Sell | $0.00 | 0.00% |
IGRW Stock Forecast | Interactive Health Network | - |
0
|
$0.00 | Buy/Sell | $0.00 | 0.00% |
McKesson Corp EBITDA Forecast for 2023 - 2025 - 2030
In the last three years, McKesson Corp's EBITDA has grown from $3.74B to $4.96B – a 32.58% increase. Next year, analysts are expecting EBITDA to reach $5.20B – an increase of 4.93%. Over the next seven years, the forecast is for EBITDA to grow by 12.50%.
McKesson Corp EBIT Forecast for 2023 - 2025 - 2030
In the last three years, McKesson Corp's EBIT has grown by 57.96%, rising from $2.82B to $4.45B. For next year, analysts predict EBIT of $4.57B, which would mean an increase of 2.61%. Over the next seven years, experts predict that McKesson Corp's EBIT will grow at a rate of 16.27%.
McKesson Corp EPS Price Prediction Forecast for 2023 - 2025 - 2030
McKesson Corp's EPS has increased by 73.51% In the last three years, going from $14.95 to $25.94. In the following year, the 9 analysts surveyed believe that McKesson Corp's EPS will decrease by 2.08%, reaching $25.40. For the next seven years, the forecast is for EPS to grow by 44.52%.